Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):455–464. doi: 10.1097/QAI.0000000000001441

Table 3.

Adjusted Means and Adjusted Mean Changes in Follow-up Measures of Retrospective Memory (WRAML2) for Specific HIV Disease Severity Measures* in Youth with PHIV

Adjusted Results
Disease Severity Measure Covariate/Level Mean (95% CI) or
Estimate (SE)
P-Value
Verbal Learning 1,2,3

  Positive Change in CD4% (continuous) −0.08 (0.03) 0.01

Verbal Delay Recall 1,2,4

  CD4% ≥ 25% at entry ≥ 25% 9.45 (8.94,9.96) 0.05
< 25% 8.60 (7.80,9.40)

Verbal Recognition 2,5

  CD4% ≥ 25% at entry ≥ 25% 9.94 (9.45, 10.44) 0.001
< 25% 8.45 (7.65, 9.24)
  Log HIV RNA VL at entry (continuous) −0.50 (0.21) 0.02

Design Memory 2,6

  Age at CDC Class C 0 – 3 years 7.63 (6.71, 8.56) 0.01
> 3 years 9.83 (8.06, 11.60)
PHIV/non-C status 9.14 (8.60, 9.69)

Note. *Table includes only those HIV disease severity measures with significant differences in adjusted means (categorical covariates) or significant regression coefficients (continuous measures). The adjusted mean and 95% CI are provided for each level of categorical covariates. For continuous covariates, the adjusted mean change (and standard error) in outcome for each one-unit change in predictor is presented. Adjusted models included the following covariates: 1-Black race; 2-age at Memory/EF entry; 3-annual household income > $20,000; 4-male sex; 5-caregiver is high school graduate; 6-caregiver is biological parent. PHIV/non-C: perinatally acquired HIV, without CDC Class C diagnosis; VL: viral load.